main-logo

ICD-10 Code C82.6A | Cutaneous follicle center lymphoma, in remission Symptoms, Diagnosis, Billing

Cutaneous follicle center lymphoma, in remission is a type of non-Hodgkin lymphoma characterized by the proliferation of B-cells in the skin. This condition is clinically significant as it can lead to skin lesions and systemic symptoms. The ICD-10 Code C82.6A facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track and manage patient outcomes.

What is ICD-10 Code C82.6A for Cutaneous follicle center lymphoma, in remission?

ICD-10 Code C82.6A represents Cutaneous follicle center lymphoma, in remission, a subtype of follicular lymphoma that primarily affects the skin. This code is used when the patient has achieved remission, indicating that the disease is not currently active. It is essential for clinical documentation and billing to accurately reflect the patient's status and treatment history.

ICD-10 Code C82.6A – Clinical Definition and Explanation of Cutaneous follicle center lymphoma, in remission

Cutaneous follicle center lymphoma, in remission is a malignancy of the skin originating from follicle center B-cells. The condition can progress from localized skin lesions to systemic involvement if not monitored and treated appropriately. Medical attention is crucial to manage symptoms and prevent recurrence.

Key Clinical Features:

  • Presence of skin lesions that may be erythematous or plaque-like.
  • Potential for pruritus or discomfort associated with skin involvement.
  • History of prior treatment indicating remission status.
  • Regular monitoring for signs of recurrence or systemic involvement.

ICD-10 Code C82.6A for Cutaneous follicle center lymphoma, in remission – SOAP Notes & Clinical Use

ICD-10 Code C82.6A is utilized in SOAP notes to document the patient's remission status, guiding treatment decisions and follow-up care. It plays a vital role in both acute and chronic care settings, ensuring comprehensive patient management.

What Does ICD-10 Code C82.6A for Cutaneous follicle center lymphoma, in remission Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C82.6A connects subjective reports of symptoms and objective clinical findings to a formal diagnosis of Cutaneous follicle center lymphoma, in remission. This code is essential for ensuring continuity of care, supporting billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code C82.6A – Cutaneous follicle center lymphoma, in remission

Management of Cutaneous follicle center lymphoma, in remission focuses on monitoring and supportive care to maintain remission and prevent recurrence.

Antibiotic Therapy:

  • Not applicable as this condition is not infectious.

Supportive Care:

  • Regular dermatological assessments to monitor skin lesions.
  • Topical therapies to manage skin symptoms.
  • Patient education on skin care and monitoring for recurrence.

Infection Control:

  • Standard precautions to prevent secondary infections of skin lesions.

How to Document Symptoms of Cutaneous follicle center lymphoma, in remission (ICD-10 C82.6A) in SOAP Notes

Subjective:

  • Patient reports no new skin lesions since last visit.
  • Denies itching or discomfort in affected areas.
  • History of previous treatments and current medications.
  • Expresses concern about potential recurrence.

Objective:

  • Physical examination reveals stable skin lesions.
  • No signs of systemic involvement noted.
  • Vital signs within normal limits.
  • Laboratory results indicate no active disease.
card-topcard-bottom

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more
hipaa-icon

SOAP Note Guidelines for Diagnosing Cutaneous follicle center lymphoma, in remission (ICD-10 Code C82.6A)

Assessment:

  • Diagnosis: Cutaneous follicle center lymphoma, in remission.
  • ICD-10 Code: C82.6A.
  • No current symptoms indicating active disease.
  • Patient's history of treatment and current status suggest stable condition.

Plan:

  • Continue regular dermatological follow-ups every 3-6 months.
  • Educate patient on signs of recurrence and skin care.
  • Monitor for any new symptoms or changes in skin lesions.
  • Schedule follow-up appointment in 3 months.

Treatment & Plan Section for ICD-10 Code C82.6A – Cutaneous follicle center lymphoma, in remission

  • Regular follow-up appointments to monitor skin condition.
  • Topical corticosteroids or other dermatological treatments as needed.
  • Patient education on self-monitoring for new lesions.
  • Psychosocial support to address concerns about recurrence.

Using ICD-10 Code C82.6A for Cutaneous follicle center lymphoma, in remission in Billing & SOAP Note Compliance

  • Ensure accurate documentation of patient history and treatment response.
  • Use C82.6A in conjunction with relevant CPT codes for dermatological services.
  • Document any changes in symptoms or treatment plans clearly.
  • Align treatment plans with clinical guidelines to support billing.

    ICD-10 Code C82.6A in Medical Billing and Insurance for Cutaneous follicle center lymphoma, in remission

    ICD-10 Code C82.6A is crucial for accurate billing in hospital, ER, or infectious disease care settings.

    Billing Notes:

    • Document all relevant patient history and treatment details to support claims.
    • Use C82.6A in appropriate clinical settings to ensure accurate coding.
    • Include key elements in charts such as treatment response and follow-up plans.
    • Ensure compliance with payer guidelines for documentation.

    Common CPT Pairings:

    CPT CodeDescription
    99213Established patient office visit, moderate complexity.
    11100Biopsy of skin, subcutaneous tissue, or mucous membrane.
    96413Chemotherapy administration, intravenous, push technique.

    Frequently Asked Questions

    Common Questions About Using ICD-10 Code C82.6A for Cutaneous follicle center lymphoma, in remission

    What does it mean if a patient is in remission?

    Being in remission means that the signs and symptoms of Cutaneous follicle center lymphoma are not currently present, indicating a positive response to treatment. Regular monitoring is essential to ensure that the condition does not recur.

    How often should patients with this diagnosis be monitored?

    Patients in remission from Cutaneous follicle center lymphoma should typically be monitored every 3 to 6 months, depending on individual risk factors and clinical judgment, to detect any signs of recurrence early.

    Can Cutaneous follicle center lymphoma return after remission?

    Yes, Cutaneous follicle center lymphoma can return after remission. Continuous follow-up and monitoring are crucial for early detection and management of any recurrence.

    What are the common treatments for this condition?

    Common treatments for Cutaneous follicle center lymphoma include topical therapies, systemic treatments, and regular dermatological assessments to manage symptoms and monitor for recurrence.

    diamond-bg
    diamond-bg

    Get started with your 20 free notes

    Sign up for free
    main-logo

    AI-aided Sudsy Shorthand for ink-free practices

    support@soapsuds.io
    hipaa-logo

    Clinical Notes

    SOAP notes

    DAP notes

    AI medical notes

    © Copyright SOAPsuds 2025. All rights reserved